Child status: buccal midazolam 🚨 👶
🚨 👶 PAEDIATRIC HIGH ALERT — EDUCATIONAL DRAFT, NOT A PRESCRIBING ORDER. Drug choice, indication, formulation, dose, route and monitoring require current BNF/BNFC, product SmPC and local NHS protocol. Source reviewed 3 November 2026; independent clinical/pharmacy sign-off pending.
🧬 Mechanism and reason for use
- Midazolam enhances GABA-A signalling; buccal rescue delivery is useful before IV access is established.
- Community/ward emergency prolonged convulsive seizure where individualised plan or local paediatric status guideline authorises buccal administration.
💊 Indication-specific UK regimen / dosing boundary
- RCUK 2025 algorithm: buccal midazolam 0.3 mg/kg (maximum 10 mg) in the paediatric convulsive status pathway, but RCUK also directs users to BNFC for exact age-related dosing and product guidance.
- Age-banded licensed buccal formulations vary: check BNFC, brand/device, the individual rescue plan and prior benzodiazepines before administration.
🔎 Before writing a prescription
- Confirm route, concentration in mg/mL, weight/age, rescue plan, number/time of doses already given; summon paediatric help and check glucose.
🧪 Monitoring and reassessment
- Airway/breathing, conscious level, blood pressure, persistent/recurrent seizure; ready for ventilation.
🚨 Serious pitfalls / when to escalate
- Confusing concentration with volume may cause overdose. Two benzodiazepine doses total (including prehospital treatment) is a key safety check.
📖 UK reference documents
Editorial status: Source checked for the specific statements above on 3 November 2026. References may be updated. This card has not had formal independent pharmacist/consultant approval; no unlisted indications, paediatric extrapolation or automatic renal-dose adjustments are implied.
